ALONEST 1.5 mg/ml, solution as a nasal spray bottle, 20 ml
Active ingredients: Azelastine, Azelastine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for sprayingbottle, 20 mlnasale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALONEST 1,5 mg/mL, solution pour pulvérisation nasale
- Pharmaceutical form
- solution pour pulvérisation
- Route of administration
- nasale
- Presentation description
- 1 flacon(s) en verre brun de 20 ml avec pompe(s) doseuse(s) polypropylène polyéthylène polyoxyméthylène élastomère acier inoxydable
- Marketing authorisation holder
- VIATRIS MEDICAL
- Reimbursement according to BDPM
- 30 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Aug 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60880110CIP73018553CIP133400930185537Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'AZÉLASTINEsolution | 1,5 mg · 1 mL de solution | SA |
| AZÉLASTINEsolution | 1,35 mg · 1 mL de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.